Lefebvre Mojgan M 4
4 · TRAVELERS COMPANIES, INC. · Filed Jul 23, 2026
Research Summary
AI-generated summary of this filing
Travelers (TRV) EVP Mojgan Lefebvre Exercises Options, Sells Shares
What Happened
Mojgan Lefebvre, EVP & Chief Technology & Operations Officer at Travelers (TRV), exercised stock options and immediately sold the resulting shares on July 21, 2026. She exercised 9,213 options at $132.58 (cost $1,221,460) and sold those shares at an average price of $368.35 for proceeds of $3,393,652. She also exercised 7,100 options at $139.83 (cost $992,793) and sold those shares at an average price of $368.40 for proceeds of $2,615,676. Total shares sold: 16,313; total gross proceeds: $6,009,328; total exercise cost: $2,214,253; approximate net cash to the insider: $3,795,075. The filings show the exercises and immediate sales (a cashless exercise pattern), so these are disposals rather than a long-term buy signal.
Key Details
- Transaction date: 2026-07-21; Form 4 filed 2026-07-23 (timely).
- Exercises (code M): 9,213 @ $132.58 and 7,100 @ $139.83.
- Open-market sales (code S): 9,213 @ avg $368.35 and 7,100 @ avg $368.40.
- Total shares sold: 16,313; gross proceeds: $6,009,328; exercise cost: $2,214,253; net ≈ $3,795,075.
- Shares owned after transaction: not reported in the provided details.
- Footnote: weighted average sale price covered a range ($368.16–$368.57); filer can provide breakdown by price on request (F1).
- No 10b5‑1 plan, gift, or tax‑withholding notation was provided in the summary data supplied.
Context
- This is an options exercise followed by immediate sale (commonly a cashless exercise), which converts compensation/options into cash; such transactions are routine for executives and do not by themselves indicate a change in view about the company.
- Transaction codes: M = exercise/conversion of derivative; S = sale.
- The filing appears timely (filed two days after the trades).
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-07-21$132.58/sh+9,213$1,221,460→ 9,213 total - Sale
Common Stock
[F1]2026-07-21$368.35/sh−9,213$3,393,652→ 0 total - Exercise/Conversion
Common Stock
2026-07-21$139.83/sh+7,100$992,793→ 7,100 total - Sale
Common Stock
2026-07-21$368.40/sh−7,100$2,615,676→ 0 total - Exercise/Conversion
Stock Options (Right to Buy)
2026-07-21−9,213→ 0 totalExercise: $132.58From: 2023-02-04Exp: 2030-02-04→ Common Stock (9,213 underlying) - Exercise/Conversion
Stock Options (Right to Buy)
2026-07-21−7,100→ 21,214 totalExercise: $139.83From: 2024-02-02Exp: 2031-02-02→ Common Stock (7,100 underlying)
Footnotes (1)
- [F1]Represents the weighted average sales price for price increments ranging from $368.16 to $368.57. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.